Biomanufacturing (BioMAN) Research Program
The objective of the MIT CBI BioMANufacturing Research Program is to develop new knowledge, science, technologies and strategies that advance the manufacture and global delivery of high quality biopharmaceuticals.
To address emerging Biomanufacturing needs, BioMAN activities are focused on:
- Advanced product and process analysis for optimized quality manufacturing
- Flexible modular platforms for biotherapeutic production and delivery
- Assessment and mitigation of risk in biopharmaceutical production
- Global delivery of biopharmaceuticals
BioMAN fosters a collaborative research environment that brings together thought leaders from industry, the government/FDA and academia.
For more information or to join BioMAN, please contact:
Stacy L. Springs, PhD
Executive Director, BioMAN
Executive Director, Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB)